…
Pantheon International PLC specializes in fund of fund investments. For fund of fund investments, it seeks to invest in private equity, buyout, venture, growth, secondary investment funds, and special situations funds globally. Within private equity, it invests in late-stage buyouts to early-stage technology funds. In United States, the fund focuses on mid-market buyout, mature venture, and growth funds. In Europe, it focuses on mid-market buyout funds and in Asia, the fund focuses on growth and buyout funds. The fund seeks to invest globally with a focus on North America, Asia, Northern Europe, and the United States. It typically invests in funds specializing in unquoted investments and acquiring unquoted portfolios. The fund also co-invests alongside private equity managers. It may invest in any type of financial instrument, including equity and non-equity shares, debt securities, subscription and conversion rights and options in relation to such shares and securities and interests in partnerships and limited partnerships and other forms of collective investment scheme. Pantheon International PLC was founded in 1987 and based in London, United Kingdom.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 | 2021-05-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 | 2021-05-31 |
| Income before tax | -4.43M | 34.68M | 43.77M | 575.67M | 302.43M |
| Net income | -6.71M | 31.65M | 42.28M | 572.60M | 305.96M |
| Selling general administrative | 3.38M | 3.49M | 4.17M | 3.38M | 3.34M |
| Selling and marketing expenses | 0.38M | 5.52M | - | - | - |
| Gross profit | 4.38M | 47.01M | 54.29M | 582.87M | 309.31M |
| Ebit | - | 41.79M | 40.96M | 560.08M | 324.37M |
| Ebitda | -4.43M | -0.45M | 43.77M | 575.77M | 302.43M |
| Depreciation and amortization | - | -42.24M | - | - | - |
| Operating income | -4.43M | 42.24M | 43.77M | 575.77M | 302.43M |
| Other operating expenses | 23.57M | 31.20M | 10.51M | 7.20M | 6.88M |
| Interest expense | 14.77M | 6.71M | 0.02M | 0.10M | 0.07M |
| Tax provision | 2.28M | 3.03M | 1.49M | 3.08M | -3.53M |
| Interest income | 1.69M | 0.64M | 0.78M | 0.03M | 0.09M |
| Net interest income | -13.08M | -6.06M | 0.76M | -0.07M | 0.02M |
| Income tax expense | 2.28M | 3.03M | 1.49M | 3.08M | -3.53M |
| Total revenue | 19.14M | 73.44M | 54.29M | 582.87M | 309.31M |
| Total operating expenses | 8.81M | 12.33M | 10.51M | 7.20M | 6.88M |
| Cost of revenue | 14.77M | 26.43M | - | - | - |
| Total other income expense net | - | -7.56M | - | -0.10M | -0.07M |
| Net income from continuing ops | -6.71M | 31.65M | 42.28M | 572.60M | 305.96M |
| Net income applicable to common shares | - | - | 42.28M | 572.60M | 305.96M |
| Breakdown | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 | 2021-05-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 | 2021-05-31 |
| Total assets | 2465.79M | 2522.86M | 2486.01M | 2472.19M | 1921.06M |
| Other current assets | 2.65M | 1.36M | - | - | - |
| Total liab | 242.75M | 239.21M | 35.94M | 44.73M | 55.83M |
| Total stockholder equity | 2223.04M | 2283.64M | 2450.07M | 2427.46M | 1865.23M |
| Other current liab | - | 87.46M | -2.25M | -2.13M | -1.65M |
| Common stock | 30.00M | 31.20M | 35.50M | 36.01M | 36.24M |
| Capital stock | 30.00M | 31.20M | 35.50M | 36.01M | 36.24M |
| Retained earnings | - | 481.71M | 520.44M | 562.02M | 579.45M |
| Other assets | - | 2522.86M | 2.04M | 1.53M | 2.56M |
| Cash | 25.42M | 21.86M | 66.04M | 231.46M | 199.12M |
| Total current liabilities | 1.81M | 91.01M | 2.25M | 2.13M | 1.65M |
| Current deferred revenue | - | -0.57M | - | - | - |
| Net debt | 211.29M | -21.86M | -33.52M | -190.08M | -146.10M |
| Short term debt | - | 83.26M | - | - | - |
| Short long term debt total | 236.71M | 113.64M | 32.52M | 41.37M | 53.02M |
| Other stockholder equity | 2193.04M | -373.47M | 2414.57M | 2391.45M | 1828.99M |
| Total current assets | 28.50M | 24.35M | 66.35M | 232.05M | 204.77M |
| Long term investments | 2437.29M | 2498.51M | 2417.62M | 2238.61M | 1713.72M |
| Net tangible assets | - | - | 2450.07M | 2427.46M | 1865.23M |
| Net receivables | 0.43M | 1.13M | 0.31M | 0.59M | 5.66M |
| Accounts payable | 1.81M | 3.55M | 2.25M | 2.13M | 1.65M |
| Accumulated other comprehensive income | - | 2144.21M | - | - | - |
| Common stock total equity | - | - | - | - | 36.24M |
| Non currrent assets other | 2437.29M | -2498.51M | -2417.62M | -2238.61M | -1713.72M |
| Non current assets total | 2437.29M | 2498.51M | 2417.62M | 2238.61M | 1713.72M |
| Breakdown | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 | 2021-05-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 | 2021-05-31 |
| Investments | 73.26M | -21.42M | -127.85M | 50.08M | 118.35M |
| Change to liabilities | - | - | 0.39M | 0.48M | 0.21M |
| Total cashflows from investing activities | 73.26M | -21.42M | -127.85M | 50.08M | 118.35M |
| Net borrowings | 18.90M | 202.10M | -5.04M | -13.79M | -24.29M |
| Total cash from financing activities | -57.21M | -4.75M | -31.78M | -27.00M | -29.17M |
| Net income | 15.36M | 31.65M | 50.14M | 579.64M | 305.92M |
| Change in cash | 3.55M | -44.18M | -165.41M | 32.34M | 69.03M |
| Begin period cash flow | 21.86M | 66.04M | 231.46M | 199.12M | 130.09M |
| End period cash flow | 25.42M | 21.86M | 66.04M | 231.46M | 199.12M |
| Total cash from operating activities | -13.12M | -17.85M | -14.99M | -10.45M | -1.76M |
| Other cashflows from investing activities | - | -27.51M | - | - | - |
| Dividends paid | 0.00M | 0.00M | - | - | - |
| Change to account receivables | -0.04M | 0.11M | -0.15M | -0.03M | 0.00M |
| Sale purchase of stock | -54.78M | -197.19M | -19.68M | -10.36M | - |
| Other cashflows from financing activities | -21.33M | -9.66M | -7.07M | -2.85M | -4.89M |
| Change to netincome | - | - | -57.52M | -583.50M | -307.95M |
| Capital expenditures | 0.00M | 27.51M | 0.00M | 0.00M | 0.00M |
| Change in working capital | -0.13M | 0.32M | 0.25M | 0.45M | 0.22M |
| Other non cash items | -28.35M | -49.82M | -65.38M | -590.54M | -307.90M |
| Free cash flow | -13.12M | -17.85M | -14.99M | -10.45M | -1.76M |
Sector: Financial Services Industry: Asset Management
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
|---|---|---|---|---|---|---|---|
| PIN Pantheon International PLC |
6.00 1.57% |
387.00 | 46.50 | - | 37.94 | 0.69 | 41.87 |
| MNTN Schiehallion Fund Ltd |
-0.01 0.46% |
2.18 | 0.05 | - | 4.35 | 1.25 | 5.65 |
| BHMU BH Macro Limited |
- -% |
4.29 | 0.09 | - | 39.01 | 0.71 | 6.47 |
| TFG Tetragon Financial Group Ltd |
0.15 1.00% |
15.10 | 0.02 | 7.04 | 1.16 | 0.31 | 2.06 |
| BPCR BioPharma Credit PLC |
0.00 0.41% |
0.98 | 0.09 | - | 6.73 | 0.91 | 7.95 |
Pantheon International PLC specializes in fund of fund investments. For fund of fund investments, it seeks to invest in private equity, buyout, venture, growth, secondary investment funds, and special situations funds globally. Within private equity, it invests in late-stage buyouts to early-stage technology funds. In United States, the fund focuses on mid-market buyout, mature venture, and growth funds. In Europe, it focuses on mid-market buyout funds and in Asia, the fund focuses on growth and buyout funds. The fund seeks to invest globally with a focus on North America, Asia, Northern Europe, and the United States. It typically invests in funds specializing in unquoted investments and acquiring unquoted portfolios. The fund also co-invests alongside private equity managers. It may invest in any type of financial instrument, including equity and non-equity shares, debt securities, subscription and conversion rights and options in relation to such shares and securities and interests in partnerships and limited partnerships and other forms of collective investment scheme. Pantheon International PLC was founded in 1987 and based in London, United Kingdom.
| Name | Title | Year Born |
|---|---|---|
| Mr. Paul Ward | Managing Partner and Partner | 1967 |
| Mr. Chris Meads | Chief Investment Officer, Asian Investment Partner, Head-Investments & Asian Primary Investment Team | NA |
| Mr. Elly Livingstone | Partner & Head of the Secondaries Team | 1964 |
| Ms. Susan Long McAndrews | Partner and Head of the North American Primary Investment Team | NA |
| Ms. Helen Steers | Partner & Head of European Primary Investments | NA |
| Mr. Dennis P. McCrary | Partner and Partner-Global Co-Investment | NA |
| Mr. Thomas Varley | Sr. Associate | NA |
| Mr. Paul Robert Ward | Managing Partner and Partner | 1967 |
| Mr. Dennis Patrick McCrary | Partner and Partner Global Co Investment | 1956 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.